Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients

By Ehsan Zarmina   Wetzel Jacqueline Denise   Clancy John P  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. : 743-749

Informa Healthcare

Access to resources Recommend Favorite

Insights into antifolate activity of phytochemicals against Pseudomonas aeruginosa

By Jayaraman Premkumar   Sakharkar Kishore R.   Sing Lim Chu   Chow Vincent T.K.   Sakharkar Meena K.  

Journal of Drug Targeting, Vol. 19, Iss. 3, 2011-04 ,pp. : 179-188

Informa Healthcare

Access to resources Recommend Favorite

Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species

By Gupta Varsha  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 2, 2008-02 ,pp. : 131-143

Informa Healthcare

Access to resources Recommend Favorite

Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials

By Máiz Luis   Girón Rosa M   Olveira Casilda   Quintana Esther   Lamas Adelaida   Pastor Dolores   Cantón Rafael   Mensa Josep  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1135-1149

Informa Healthcare

Access to resources Recommend Favorite

Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies

By Hassett Daniel J   Korfhagen Thomas R   Irvin Randall T   Schurr Michael J   Sauer Karin   Lau Gee W   Sutton Mark D   Yu Hongwei   Hoiby Niels  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 2, 2010-02 ,pp. : 117-130

Informa Healthcare

Access to resources Recommend Favorite